Anhydrous enol oxaloacetate is under clinical development by MetVital and currently in Phase II for Fatigue. According to GlobalData, Phase II drugs for Fatigue does not have sufficient historical ...

Chronic inflammation often flies under the radar, subtly damaging the body over time. Unlike acute inflammation, which helps the body heal from injuries or infections, chronic inflammation lingers, ...

Norketotifen is under clinical development by Emergo Therapeutics and currently in Phase II for Unspecified Influenza Virus Infections.